Figure 1.
Expression patterns of enhancer of zeste homolog 2 (EZH2) were served in 117 cervical squamous cell carcinomas (CSCCs) and 23 adjacent normal tissues. (A) Histogram shows expression levels of EZH2 in CSCC and adjacent normal tissues by immunoreactive score (IRS). (B and C) Expression and localization of EZH2 in adjacent normal tissues (A, original magnification, x100; B, original magnification, x400). (D and E) Expression and localization of EZH2 in CSCCs (C, original magnification, x100; D, original magnification, x400).